海外の治験の状況「前立腺癌」での検索結果
161件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
- Prostate Cancer
- Australia, New Zealand
- 2005-05-03
Not recruiting
- MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)
- Prostatic Neoplasms;Prostatic Neoplasms
- Australia, France, New Zealand, United States
- 2006-03-09
Not recruiting
- (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer
- Non-Metastatic Prostate Cancer
- Australia, Austria, Belgium, Czech Republic, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Poland, Portugal, South Africa, Spain, United Kingdom
- 2008-05-02
Not recruiting
- First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer
- Prostatic Neoplasms
- Austria, Germany
- 2012-11-01
Recruiting
- Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
- Metastatic Castration-Resistant Prostate Cancer
- Australia, Canada, France, Germany, New Zealand, Spain, United Kingdom, United States
- 2016-08-03
Recruiting
- Oral Docetaxel for Prostate Cancer
- Metastatic prostate cancer; br>Metastatic prostate cancer;Cancer - Prostate
- New Zealand
- 2016-07-27
Authorised
- An International Study to Evaluate the Safety and Effectiveness of MDV3100 in Patients with Prostate Cancer Where Their Cancer Has Progressed Despite Hormonal Therapy
- Chemotherapy-Naïve Patients with Progressive Metastatic Prostate Cancer Who Have Failed Androgen Deprivation Therapy MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Israel, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, Poland, Russian Federation, Singapore, Slovakia, Spain, Sweden, United Kingdom, United States
- 2010-07-14
Not Recruiting
- Radium-223 Dichloride in the treatment of patients diagnosed with prostate cancer that has spread to the bone
- Castrate Resistant Prostate Cancer/Hormone-Refractory Prostate Cancer patients with bone metastasis MedDRA version: 18.1 Level: LLT Classification code 10036916 Term: Prostate cancer stage D System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, Belgium, Canada, Czech Republic, Denmark, Finland, Germany, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
- 2012-03-28
Recruiting
- A Multinational, Phase 3, Randomized, Double Blind, Placebo Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration Resistant Prostate Cancer
- Nonmetastatic Castration-Resistant Prostate Cancer # Prostate Cancer # Cancer of the Prostate;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Taiwan, Province of China, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2015-06-23
Not recruiting
- Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
- Prostatic Neoplasms
- Australia, Austria, Belgium, Ireland, New Zealand, Slovenia, Spain, United Kingdom, United States
- 2015-05-04
